Joseph Lasaga
Corporate Officer/Principal chez RIGEL PHARMACEUTICALS, INC.
Postes actifs de Joseph Lasaga
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/1998 | - |
Historique de carrière de Joseph Lasaga
Anciens postes connus de Joseph Lasaga
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Corporate Officer/Principal | 01/12/2014 | 01/10/2016 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/01/2012 | 01/08/2014 |
Formation de Joseph Lasaga
| San Francisco State University | Masters Business Admin |
| San Jose State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Entreprise privées | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Bourse
- Insiders
- Joseph Lasaga
- Expérience
